Clinical Trial: Phase III Clinical Trial of SHPL-49 Injection in the Treatment of Acute Ischemic Stroke

U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07241520) titled 'Phase III Clinical Trial of SHPL-49 Injection in the Treatment of Acute Ischemic Stroke' on Nov. 17.

Brief Summary: This study is designed to determine the efficacy and safety of SHPL-49 intravenous infusion in acute ischemic stroke patients.

Study Start Date: Nov. 30

Study Type: INTERVENTIONAL

Condition: Acute Ischemic Stroke

Intervention: DRUG: SHPL-49 Injection

2 ampoules of SHPL-49 Injection in 100 mL 0.9% sodium chloride will be administered as a 30-minute intravenous infusion and applied twice daily for 7 days.

DRUG: Placebo Injection

2 ampoules of Placebo Injection in 100 mL 0.9% sodium chloride will be administered ...